Here are the S-3 shelf registrations from Lucid Diagnostics Inc. (LUCD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow LUCD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LUCD filings page.
Lucid Diagnostics files a shelf registration to offer up to $175,000,000 of common stock, preferred stock, debt securities, warrants and/or units, subject to completion. The filing includes an ATM prospectus supplement for an at-the-market program to sell up to $25,000,000 of common stock under a Sales Agreement with Maxim Group LLC. The prospectus states that unsold securities of $50,000,000 from a prior registration are folded into this filing. As context, shares outstanding were 176,945,972 as of March 20, 2026. Specific terms, distribution methods, pricing, and proceeds treatment will be provided in future prospectus supplements.